Drug repurposing to treat Viruses: COVID-19

Tracks 16: Drug repurposing to treat Viruses: COVID-19

 

<p 0px="" 16:="" background-color:="" drug="" margin:="" n="" p="" repurposing="" style="" text-align:"="" text-align:="" to="" tracks="" treat="" viruses:=""> Drug repurposing is a methodology for making more value from an existing drug by targeting diseases by focusing on infections other than that for which it was initially proposed, For instance, teicoplanin, oritavancin, dalbavancin and monensin are affirmed antibiotics that have been appeared to inhibit corona- and other viruses in the research facility. The researchers reviewed information on the discovery and development of wide-spectrum antiviral agents (BSAAs), which are drugs that target viruses from two or more different viral families. They condensed what they found for 120 drugs that had just been demonstrated to be ok for people use and made a database, which is uninhibitedly available Thirty-one of these were found by the researchers to be possible candidates for prophylaxis and treatment of the COVID-19 infections. The researchers also found that clinical investigations have recently begun of five possible drug candidates to treat the virus that causes COVID-19.

  • Corona Virus Drugs
  • Coronavirus vaccine by Immuno Precise Antibodies
  • Clinical Development of Drugs
  • Targets for Antiviral Drugs

Related Conference of Drug repurposing to treat Viruses: COVID-19

May 10-11, 2021

20th Annual Meet on Pharmaceutical Sciences

Yokohama, Japan
May 12-12, 2021

27th Cognitive Neuroscience Congress

London, UK
May 17-17, 2021

Annual Meet on Pharmacovigilance & Drug Safety

Tokyo, Japan
May 17-18, 2021

8th European Biopharma Congress

Prague, Czech Republic
June 07-08, 2021

2nd European Conference on Pharmacovigilance and Drug Safety

Prague, Czech Republic
June 21-22, 2021

1 st Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
July 06-07, 2021

14th Global Pharmacovigilance And Clinical Trials Summit

Albufeira, Portugal
July 10-11, 2021

2 nd Pharma Expo China

Tokyo, Japan
July 13-14, 2021

24th Asia Pacific Pharma Congress

Melbourne,
July 26-27, 2021

36th World Pharmacology and Therapeutics Forum

Paris, France
July 30-30, 2021

12th World Congress on Bioavailability and Bioequivalence

Prague, Czech Republic
August 16-17, 2021

Global summit on Cosmetic & Reconstructive Surgery

Tokyo, Japan
August 16-17, 2021

34rd World Congress on Pharmacology

London, UK
August 23-24, 2021

7th World Congress on Medicinal Plants and Marine Drugs

Prague, Czech Republic
August 30-31, 2021

20th Medicinal & PharmaceuticalSciences Congress

London, UK
September 13-14, 2021

3rd World Congress on Drug Discovery and Drug Design

Tokyo, Japan
September 17-18, 2021

9th International Conference on Clinical Trials

Montreal, Canada
September 20-21, 2021

Asia Pacific Pharmaceutics & Drug Delivery Congress

Tokyo, Japan
September 27-28, 2021

2 nd World Pharma Expo

Tokyo, Japan
October 05-06, 2021

International Congress on Drug Delivery

Auckland, Newzealand
October 21-22, 2021

2nd Annual Congress on Antibiotics and Bacterial Infections

Geneva, Switzerland
October 29-30, 2021

14th World Drug Delivery Summit

Vancouver, Canada
October 29-30, 2021

12th Annual Biomarkers and Clinical Research Congress

Vancouver, Canada
November 16-17, 2021

World Congress on Biologics and Biosimilars

Osaka, Japan
November 26-27, 2021

World Biosimilars & Biologics Congress

Vancouver, Canada
December 02-03, 2021

17th Annual Congress on Pharmacology and Toxicology

Tokyo, Japan
December 02-03, 2021

International Conference on Bio Pharmaceutics

Auckland, Newzealand
December 07-08, 2021

2nd International Conference on Biotechnology and Healthcare

Auckland, Newzealand
December 15-16, 2021

12th World Congress on Bioavailability and Bioequivalence

Bali, Indonesia

Drug repurposing to treat Viruses: COVID-19 Conference Speakers

Recommended Sessions

Related Journals

Are you interested in